Together, these findings using small-molecule perturbation of SHP2 further corroborate the essentiality of PTPN11 in various models of chordoma, and thus nominate SHP2 inhibitors as a therapeutic approach for the treatment of chordoma. The gene discussed is PTPN11; the disease is chordoma.